RNA5SP174: A Potential Drug Target and Biomarker (G106478998)

Target Name: RNA5SP174

NCBI ID: G106478998

RNA5SP174

Other Name(s): RN5S174 | RNA, 5S ribosomal pseudogene 174

RNA5SP174: A Potential Drug Target and Biomarker

Introduction

RNA5SP174 is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. It is a key regulator of the cell cycle and is involved in the development, maintenance, and progression of cancer. RNA5SP174 has been shown to be highly expressed in various types of cancer, including breast, ovarian, and colorectal cancers. The potential drug target for RNA5SP174 makes it an attractive candidate for cancer treatment.

The cell cycle is a critical process for the growth, development, and progression of cancer. The cell cycle is the set of instructions that guides a cell from the state of mitosis to the state ofG1 DNA replication, and it is a critical regulatory process for the development of cancer. RNA5SP174 is a key regulator of the cell cycle and is involved in the regulation of the G1/S transition, which is a critical step in the cell cycle.

The G1/S transition is a critical step in the cell cycle that is associated with the entry of the cell into the S phase of the cell cycle. During the G1 phase, the cell grows, prepares for cell division, and replicates its DNA. In the S phase, the cell replicates its RNA, prepares for cell division, and enters the G2 phase. The G1/S transition is critical for the regulation of the cell cycle and is associated with the development and progression of cancer.

RNA5SP174 is involved in the regulation of the G1/S transition by promoting the transition from G1 to S phase and by inhibiting the transition from S to G2 phase. Studies have shown that RNA5SP174 is highly expressed in various types of cancer, including breast, ovarian , and colorectal cancers. This suggests that RNA5SP174 may be a useful biomarker for the diagnosis and treatment of cancer.

In addition to its role in the cell cycle, RNA5SP174 has also been shown to be involved in the regulation of cell adhesion and migration. Studies have shown that RNA5SP174 plays a role in the regulation of tight junction formation and has been shown to be involved in the regulation of cell migration.

Furthermore, RNA5SP174 has also been shown to be involved in the regulation of apoptosis, which is a critical process for the regulation of cell death. Studies have shown that RNA5SP174 plays a role in the regulation of apoptosis by activating the B-cell lymphoma 1 (Bcl -1) gene. Bcl-1 is a critical regulator of apoptosis and has been shown to be involved in the regulation of cancer cell death.

In conclusion, RNA5SP174 is a non-coding RNA molecule that is involved in the regulation of the cell cycle, cell adhesion, and apoptosis. Its high expression in various types of cancer makes it an attractive candidate for cancer treatment. Further research is needed to determine the full role of RNA5SP174 in the development and progression of cancer.

Protein Name: RNA, 5S Ribosomal Pseudogene 174

The "RNA5SP174 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about RNA5SP174 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets